Results 1 to 10 of about 9,898 (104)

Lipid metabolism in γδ T-cell activation: Implications for immunotherapy in ovarian cancer [PDF]

open access: yesTranslational Oncology
Ovarian cancer (OC) remains a leading cause of cancer-related mortality among women worldwide, largely due to asymptomatic progression, late-stage diagnosis, therapeutic resistance, and profound immunosuppression within the tumor microenvironment (TME ...
Karolina Stirblyte   +9 more
doaj   +2 more sources

CD36 Signal Transduction in Metabolic Diseases: Novel Insights and Therapeutic Targeting

open access: yesCells, 2021
The cluster of differentiation 36 (CD36) is a scavenger receptor present on various types of cells and has multiple biological functions that may be important in inflammation and in the pathogenesis of metabolic diseases, including diabetes.
Kyu Chang Won   +2 more
exaly   +3 more sources

Plasma CD36 and Incident Diabetes: A Case-Cohort Study in Danish Men and Women [PDF]

open access: yesDiabetes & Metabolism Journal, 2020
BackgroundMembrane CD36 is a fatty acid transporter implicated in the pathogenesis of metabolic disease. We aimed to evaluate the association between plasma CD36 levels and diabetes risk and to examine if the association was independent of adiposity ...
Yeli Wang   +8 more
doaj   +1 more source

The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond [PDF]

open access: yesDiabetes & Metabolism Journal, 2020
Impaired β-cell function is the key pathophysiology of type 2 diabetes mellitus, and chronic exposure of nutrient excess could lead to this tragedy.
Jun Sung Moon   +4 more
doaj   +1 more source

Matching strategy for patients with platelet transfusion refractoriness caused by compound antibodies against HLA and CD36

open access: yesZhongguo shuxue zazhi, 2023
Objective To search compatible and suitable platelets for platelet transfusion refractoriness (PTR) patient caused by compound antibodies against HLA and CD36.
Jing DENG   +10 more
doaj   +1 more source

Analysis and prospect of platelet compatible transfusion

open access: yesZhongguo shuxue zazhi, 2022
Platelet compatible transfusion can effectively solve the immune mediated platelet transfusion refractoriness (PTR), save platelet resources and improve blood safety.
Faming ZHU, Wei MAO, Zhixin ZHANG
doaj   +1 more source

Hypochlorous acid-modified human serum albumin suppresses MHC class II - dependent antigen presentation in pro-inflammatory macrophages

open access: yesRedox Biology, 2021
Macrophages are innate immune cells that internalize and present exogenous antigens to T cells via MHC class II proteins. They operate at sites of infection in a highly inflammatory environment, generated in part by reactive oxygen species, in particular
Agnes Ulfig   +5 more
doaj   +1 more source

Neonatal Intracranial Hemorrhage with a Dramatic Outcome Due to Maternal Anti CD36 Antibodies

open access: yesReports, 2019
Fetal/neonatal allo-immune thrombocytopenia (FNAIT) results from maternal immunization against fetal platelet-specific antigens (HPA) inherited from the father. Most cases involve HPA located on glycoproteins (GP) IbIX, IaIIa and IIbIIIa.
Gérald Bertrand   +5 more
doaj   +1 more source

Nanoparticles Containing Curcumin Useful for Suppressing Macrophages In Vivo in Mice. [PDF]

open access: yesPLoS ONE, 2015
To explore a novel method using liposomes to suppress macrophages, we screened food constituents through cell culture assays. Curcumin was one of the strongest compounds exhibiting suppressive effects on macrophages. We subsequently tried various methods
Chie Amano   +6 more
doaj   +1 more source

Overcoming β-Cell Dysfunction in Type 2 Diabetes Mellitus: CD36 Inhibition and Antioxidant System [PDF]

open access: yesDiabetes & Metabolism Journal
Type 2 diabetes mellitus (T2DM) is marked by chronic hyperglycemia, gradually worsening β-cell failure, and insulin resistance. Glucotoxicity and oxidative stress cause β-cell failure by increasing reactive oxygen species (ROS) production, impairing ...
Il Rae Park   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy